Novel protein kinase D inhibitors cause potent arrest in prostate cancer cell growth and motility
Open Access
- 5 May 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Chemical Biology
- Vol. 10 (1), 5-16
- https://doi.org/10.1186/1472-6769-10-5
Abstract
Background: Protein kinase D (PKD) has been implicated in a wide range of cellular processes and pathological conditions including cancer. However, targeting PKD therapeutically and dissecting PKD-mediated cellular responses remains difficult due to lack of a potent and selective inhibitor. Previously, we identified a novel pan-PKD inhibitor, CID755673, with potency in the upper nanomolar range and high selectivity for PKD. In an effort to further enhance its selectivity and potency for potentialin vivoapplication, small molecule analogs of CID755673 were generated by modifying both the core structure and side-chains.Results: After initial activity screening, five analogs with equal or greater potencies as CID755673 were chosen for further analysis: kb-NB142-70, kb-NB165-09, kb-NB165-31, kb-NB165-92, and kb-NB184-02. Our data showed that modifications to the aromatic core structure in particular significantly increased potency while retaining high specificity for PKD. When tested in prostate cancer cells, all compounds inhibited PMA-induced autophosphorylation of PKD1, with kb-NB142-70 being most active. Importantly, these analogs caused a dramatic arrest in cell proliferation accompanying elevated cytotoxicity when applied to prostate cancer cells. Cell migration and invasion were also inhibited by these analogs with varying potencies that correlated to their cellular activity.Conclusions: Throughout the battery of experiments, the compounds kb-NB142-70 and kb-NB165-09 emerged as the most potent and specific analogsin vitroand in cells. These compounds are undergoing further testing for their effectiveness as pharmacological tools for dissecting PKD function and as potential anti-cancer agents in the treatment of prostate cancer.Keywords
This publication has 42 references indexed in Scilit:
- CID755673 enhances mitogenic signaling by phorbol esters, bombesin and EGF through a protein kinase D-independent pathwayBiochemical and Biophysical Research Communications, 2009
- Potent and Selective Disruption of Protein Kinase D Functionality by a BenzoxoloazepinoloneJournal of Biological Chemistry, 2008
- Sequential Protein Kinase C (PKC)-dependent and PKC-independent Protein Kinase D Catalytic Activation via Gq-coupled ReceptorsJournal of Biological Chemistry, 2008
- pRb-Dependent Cyclin D3 Protein Stabilization Is Required for Myogenic DifferentiationMolecular and Cellular Biology, 2007
- Protein kinase D 3 is localized in vesicular structures and interacts with vesicle-associated membrane protein 2Cellular Signalling, 2007
- Mitochondrial ROS – radical detoxification, mediated by protein kinase DTrends in Cell Biology, 2007
- Cdk1: the dominant sibling of Cdk2Nature, 2005
- Protein Kinase D-Mediated Anterograde Membrane Trafficking Is Required for Fibroblast MotilityCurrent Biology, 2004
- Activation Loop Ser744 and Ser748 in Protein Kinase D Are Transphosphorylated in VivoJournal of Biological Chemistry, 2001
- An invasion-related complex of cortactin, paxillin and PKCμ associates with invadopodia at sites of extracellular matrix degradationOncogene, 1999